Aardvark Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Aardvark Therapeutics Inc is a U.S.-based biotechnology company focused on the development of small molecule therapeutics for the treatment of metabolic and inflammatory diseases. The company engages in research and clinical development aimed at modulating specific biological pathways to address unmet medical needs. Aardvark Therapeutics operates through internal R&D efforts and collaborations with academic and industry partners. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AARD
Country
🇺🇸 United States